

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 8.55436553 |
| 2 | central nervous system myelination (GO:0022010) | 8.55436553 |
| 3 | fatty acid elongation (GO:0030497) | 6.24546857 |
| 4 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.21177059 |
| 5 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.00412154 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.88209741 |
| 7 | myelination (GO:0042552) | 4.82653871 |
| 8 | axon ensheathment (GO:0008366) | 4.77400424 |
| 9 | ensheathment of neurons (GO:0007272) | 4.77400424 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.71879684 |
| 11 | ATP synthesis coupled proton transport (GO:0015986) | 4.71879684 |
| 12 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.66506525 |
| 13 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.64142254 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.63070176 |
| 15 | behavioral response to nicotine (GO:0035095) | 4.59720123 |
| 16 | presynaptic membrane assembly (GO:0097105) | 4.52623903 |
| 17 | presynaptic membrane organization (GO:0097090) | 4.51190255 |
| 18 | establishment of mitochondrion localization (GO:0051654) | 4.42740807 |
| 19 | cholesterol biosynthetic process (GO:0006695) | 4.40503376 |
| 20 | sequestering of actin monomers (GO:0042989) | 4.36731703 |
| 21 | platelet dense granule organization (GO:0060155) | 4.00606788 |
| 22 | protein neddylation (GO:0045116) | 3.99952959 |
| 23 | negative regulation of neurotransmitter transport (GO:0051589) | 3.99184495 |
| 24 | chaperone-mediated protein transport (GO:0072321) | 3.92587639 |
| 25 | sterol biosynthetic process (GO:0016126) | 3.87817678 |
| 26 | substantia nigra development (GO:0021762) | 3.82509042 |
| 27 | respiratory electron transport chain (GO:0022904) | 3.76783940 |
| 28 | regulation of collateral sprouting (GO:0048670) | 3.73259376 |
| 29 | electron transport chain (GO:0022900) | 3.66536691 |
| 30 | DNA strand renaturation (GO:0000733) | 3.63580721 |
| 31 | ubiquinone biosynthetic process (GO:0006744) | 3.62193884 |
| 32 | isoprenoid biosynthetic process (GO:0008299) | 3.61563837 |
| 33 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.58719937 |
| 34 | ubiquinone metabolic process (GO:0006743) | 3.51976098 |
| 35 | nucleobase catabolic process (GO:0046113) | 3.51298589 |
| 36 | photoreceptor cell differentiation (GO:0046530) | 3.44858027 |
| 37 | eye photoreceptor cell differentiation (GO:0001754) | 3.44858027 |
| 38 | GPI anchor biosynthetic process (GO:0006506) | 3.37987388 |
| 39 | negative regulation of protein localization to cell surface (GO:2000009) | 3.36277984 |
| 40 | oligodendrocyte differentiation (GO:0048709) | 3.35762927 |
| 41 | transmission of nerve impulse (GO:0019226) | 3.34186931 |
| 42 | proteasome assembly (GO:0043248) | 3.32832529 |
| 43 | protein-cofactor linkage (GO:0018065) | 3.21642709 |
| 44 | ATP biosynthetic process (GO:0006754) | 3.20578675 |
| 45 | GPI anchor metabolic process (GO:0006505) | 3.19745691 |
| 46 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.19274703 |
| 47 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.19274703 |
| 48 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.19226140 |
| 49 | neuron recognition (GO:0008038) | 3.18846685 |
| 50 | metallo-sulfur cluster assembly (GO:0031163) | 3.16989057 |
| 51 | iron-sulfur cluster assembly (GO:0016226) | 3.16989057 |
| 52 | DNA damage response, detection of DNA damage (GO:0042769) | 3.13446604 |
| 53 | neurotransmitter uptake (GO:0001504) | 3.11429674 |
| 54 | limb bud formation (GO:0060174) | 3.09193142 |
| 55 | DNA deamination (GO:0045006) | 3.08825046 |
| 56 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.08029364 |
| 57 | mannosylation (GO:0097502) | 3.07723687 |
| 58 | glycerophospholipid catabolic process (GO:0046475) | 3.06632893 |
| 59 | neuronal action potential propagation (GO:0019227) | 3.05196743 |
| 60 | positive regulation of synapse assembly (GO:0051965) | 3.04822702 |
| 61 | ribosomal small subunit assembly (GO:0000028) | 3.03453281 |
| 62 | hydrogen ion transmembrane transport (GO:1902600) | 3.02624002 |
| 63 | regulation of dopamine metabolic process (GO:0042053) | 3.01454271 |
| 64 | regulation of catecholamine metabolic process (GO:0042069) | 3.01454271 |
| 65 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.00343258 |
| 66 | positive regulation of action potential (GO:0045760) | 3.00328802 |
| 67 | dendritic spine morphogenesis (GO:0060997) | 2.98116734 |
| 68 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.98116560 |
| 69 | respiratory chain complex IV assembly (GO:0008535) | 2.96649034 |
| 70 | regulation of feeding behavior (GO:0060259) | 2.96520504 |
| 71 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94809934 |
| 72 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.94314386 |
| 73 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.93784277 |
| 74 | apical protein localization (GO:0045176) | 2.92033702 |
| 75 | cytochrome complex assembly (GO:0017004) | 2.91802999 |
| 76 | anterograde synaptic vesicle transport (GO:0048490) | 2.90877483 |
| 77 | negative regulation of telomere maintenance (GO:0032205) | 2.89396362 |
| 78 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.87942794 |
| 79 | amyloid precursor protein metabolic process (GO:0042982) | 2.87850340 |
| 80 | neural nucleus development (GO:0048857) | 2.87500585 |
| 81 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.87035802 |
| 82 | cell proliferation in forebrain (GO:0021846) | 2.85775169 |
| 83 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.85461479 |
| 84 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.85461479 |
| 85 | NADH dehydrogenase complex assembly (GO:0010257) | 2.85461479 |
| 86 | regulation of mitochondrial translation (GO:0070129) | 2.85255080 |
| 87 | protein complex biogenesis (GO:0070271) | 2.83549173 |
| 88 | proton transport (GO:0015992) | 2.82567282 |
| 89 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.81832259 |
| 90 | nonmotile primary cilium assembly (GO:0035058) | 2.79521941 |
| 91 | response to methylmercury (GO:0051597) | 2.79260705 |
| 92 | viral transcription (GO:0019083) | 2.78911524 |
| 93 | adult walking behavior (GO:0007628) | 2.78789999 |
| 94 | quinone biosynthetic process (GO:1901663) | 2.77885825 |
| 95 | dopamine biosynthetic process (GO:0042416) | 2.77778924 |
| 96 | hydrogen transport (GO:0006818) | 2.77205077 |
| 97 | protein localization to synapse (GO:0035418) | 2.75109818 |
| 98 | negative regulation of axonogenesis (GO:0050771) | 2.74215488 |
| 99 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.74160257 |
| 100 | astrocyte development (GO:0014002) | 2.74108170 |
| 101 | protein polyglutamylation (GO:0018095) | 2.73697763 |
| 102 | inner mitochondrial membrane organization (GO:0007007) | 2.73095845 |
| 103 | translational termination (GO:0006415) | 2.72765659 |
| 104 | negative regulation of microtubule polymerization (GO:0031115) | 2.72413056 |
| 105 | protein palmitoylation (GO:0018345) | 2.71537299 |
| 106 | postsynaptic membrane organization (GO:0001941) | 2.70948287 |
| 107 | asymmetric protein localization (GO:0008105) | 2.70195890 |
| 108 | synaptic transmission, cholinergic (GO:0007271) | 2.69195331 |
| 109 | magnesium ion transport (GO:0015693) | 2.68986044 |
| 110 | cranial nerve development (GO:0021545) | 2.68231653 |
| 111 | intracellular protein transmembrane import (GO:0044743) | 2.67743538 |
| 112 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.67724992 |
| 113 | oxidative phosphorylation (GO:0006119) | 2.67320452 |
| 114 | axonal fasciculation (GO:0007413) | 2.67136580 |
| 115 | response to redox state (GO:0051775) | 2.67123505 |
| 116 | positive regulation of mitochondrial fission (GO:0090141) | 2.66114849 |
| 117 | negative regulation of axon extension (GO:0030517) | 2.66104232 |
| 118 | mechanosensory behavior (GO:0007638) | 2.64853267 |
| 119 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.64454335 |
| 120 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.62348050 |
| 121 | L-amino acid import (GO:0043092) | 2.62215784 |
| 122 | axon development (GO:0061564) | 2.62101508 |
| 123 | myelin maintenance (GO:0043217) | 2.61526066 |
| 124 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.61524448 |
| 125 | establishment of protein localization to mitochondrion (GO:0072655) | 2.61118453 |
| 126 | cornea development in camera-type eye (GO:0061303) | 2.60666236 |
| 127 | neural tube formation (GO:0001841) | 2.60347649 |
| 128 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.60150487 |
| 129 | mitochondrion transport along microtubule (GO:0047497) | 2.60150487 |
| 130 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.59944488 |
| 131 | dendrite development (GO:0016358) | 2.59434191 |
| 132 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.59109837 |
| 133 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.58507838 |
| 134 | base-excision repair, AP site formation (GO:0006285) | 2.58353561 |
| 135 | epithelial cilium movement (GO:0003351) | 2.58040134 |
| 136 | synaptic vesicle exocytosis (GO:0016079) | 2.57997184 |
| 137 | glutamate receptor signaling pathway (GO:0007215) | 2.57872075 |
| 138 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.54934703 |
| 139 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.54855982 |
| 140 | nucleotide transmembrane transport (GO:1901679) | 2.54588539 |
| 141 | protein targeting to mitochondrion (GO:0006626) | 2.54367126 |
| 142 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.54240301 |
| 143 | translational elongation (GO:0006414) | 2.54183387 |
| 144 | rRNA modification (GO:0000154) | 2.53469688 |
| 145 | termination of RNA polymerase III transcription (GO:0006386) | 2.51987485 |
| 146 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.51987485 |
| 147 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.50974335 |
| 148 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.50073184 |
| 149 | cellular component biogenesis (GO:0044085) | 2.49737792 |
| 150 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.49003901 |
| 151 | ceramide biosynthetic process (GO:0046513) | 2.48873060 |
| 152 | neuron remodeling (GO:0016322) | 2.47854274 |
| 153 | protein localization to mitochondrion (GO:0070585) | 2.47579741 |
| 154 | regulation of cilium movement (GO:0003352) | 2.47478943 |
| 155 | regulation of action potential (GO:0098900) | 2.47325563 |
| 156 | C-terminal protein lipidation (GO:0006501) | 2.46406416 |
| 157 | glycolipid biosynthetic process (GO:0009247) | 2.46325831 |
| 158 | membrane assembly (GO:0071709) | 2.46117897 |
| 159 | retinal ganglion cell axon guidance (GO:0031290) | 2.46007224 |
| 160 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.45870996 |
| 161 | membrane hyperpolarization (GO:0060081) | 2.45404922 |
| 162 | positive regulation of protein homodimerization activity (GO:0090073) | 2.44883448 |
| 163 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.44294656 |
| 164 | intraciliary transport (GO:0042073) | 2.44247079 |
| 165 | cotranslational protein targeting to membrane (GO:0006613) | 2.43623536 |
| 166 | neuron fate determination (GO:0048664) | 2.43280659 |
| 167 | startle response (GO:0001964) | 2.43270697 |
| 168 | cerebellar granule cell differentiation (GO:0021707) | 2.42368385 |
| 169 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.40572442 |
| 170 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.40456816 |
| 171 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.38318699 |
| 172 | protein targeting to ER (GO:0045047) | 2.37720336 |
| 173 | protein localization to cilium (GO:0061512) | 2.36738299 |
| 174 | GTP biosynthetic process (GO:0006183) | 2.36264436 |
| 175 | peptidyl-histidine modification (GO:0018202) | 2.35732240 |
| 176 | mitochondrial transport (GO:0006839) | 2.35007596 |
| 177 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.34104994 |
| 178 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.33766185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.45879033 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.96300880 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.66439365 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.28835112 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.21014192 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.99031445 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.78801702 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.67005871 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.62064457 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.58338801 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.49492940 |
| 12 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.46523779 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.46034479 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.39378305 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.33817483 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.23550423 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22572788 |
| 18 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.20713116 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.19485807 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.19318280 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17918838 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.14442908 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.14442908 |
| 24 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.14430021 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.12720129 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10905154 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.10092906 |
| 28 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.09513427 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08488546 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.06023082 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.03600658 |
| 32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02796884 |
| 33 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.98473948 |
| 34 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.96995534 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.95856253 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.89955781 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.86916596 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.84879703 |
| 39 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.82477818 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.80638639 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.79716884 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.78034100 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.75134505 |
| 44 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.74744139 |
| 45 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.74639177 |
| 46 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.72559000 |
| 47 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.71237409 |
| 48 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.70194097 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.63902325 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.63616330 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.62752661 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.61467905 |
| 53 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.59705743 |
| 54 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.58530798 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57745720 |
| 56 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.55898933 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50567420 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49685157 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49500332 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46360443 |
| 61 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.45051234 |
| 62 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.44761393 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.44356374 |
| 64 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39625768 |
| 65 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.39448173 |
| 66 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.36301758 |
| 67 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.35121916 |
| 68 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34789799 |
| 69 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.34093655 |
| 70 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.34084931 |
| 71 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32733857 |
| 72 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31301197 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28528212 |
| 74 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.28398987 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28187611 |
| 76 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.25791463 |
| 77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24212534 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22949834 |
| 79 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.22288268 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21512177 |
| 81 | EWS_26573619_Chip-Seq_HEK293_Human | 1.21459487 |
| 82 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.19682267 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17446822 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15986638 |
| 85 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15909085 |
| 86 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.15728644 |
| 87 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.14153182 |
| 88 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13509133 |
| 89 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.13153091 |
| 90 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13097100 |
| 91 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.12035493 |
| 92 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11022813 |
| 93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.10156135 |
| 94 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.09984483 |
| 95 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.07925546 |
| 96 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07450409 |
| 97 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.07200202 |
| 98 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.06970128 |
| 99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06607807 |
| 100 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04590420 |
| 101 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04485429 |
| 102 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04327176 |
| 103 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04218617 |
| 104 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04083831 |
| 105 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.03974638 |
| 106 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01975091 |
| 107 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01711050 |
| 108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01559750 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01466177 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01466177 |
| 111 | NCOR_22424771_ChIP-Seq_293T_Human | 1.01343002 |
| 112 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.01204412 |
| 113 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.00219593 |
| 114 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00076708 |
| 115 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99205124 |
| 116 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97979589 |
| 117 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.97969810 |
| 118 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97150541 |
| 119 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96825320 |
| 120 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95697558 |
| 121 | JUN_21703547_ChIP-Seq_K562_Human | 0.95426658 |
| 122 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.95396851 |
| 123 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95093637 |
| 124 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.94767348 |
| 125 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93901790 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93670226 |
| 127 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93084182 |
| 128 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.92416888 |
| 129 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.92082059 |
| 130 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.92082059 |
| 131 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91121745 |
| 132 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91011681 |
| 133 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.90901638 |
| 134 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90852335 |
| 135 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90617336 |
| 136 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89538096 |
| 137 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.89359930 |
| 138 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88996330 |
| 139 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88996330 |
| 140 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88736625 |
| 141 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88581809 |
| 142 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87885524 |
| 143 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87523576 |
| 144 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86763585 |
| 145 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86497725 |
| 146 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86463838 |
| 147 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.85762548 |
| 148 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.85006759 |
| 149 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.84733623 |
| 150 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.82520850 |
| 151 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.82363090 |
| 152 | ERA_21632823_ChIP-Seq_H3396_Human | 0.82022100 |
| 153 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.81816256 |
| 154 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.81481772 |
| 155 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.81066452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.45814652 |
| 2 | MP0001529_abnormal_vocalization | 3.55777021 |
| 3 | MP0000920_abnormal_myelination | 3.36218299 |
| 4 | MP0005423_abnormal_somatic_nervous | 3.19575962 |
| 5 | MP0002822_catalepsy | 2.99129007 |
| 6 | MP0004270_analgesia | 2.86099331 |
| 7 | MP0001905_abnormal_dopamine_level | 2.74843574 |
| 8 | MP0003646_muscle_fatigue | 2.67286795 |
| 9 | MP0002272_abnormal_nervous_system | 2.66650887 |
| 10 | MP0001486_abnormal_startle_reflex | 2.56451703 |
| 11 | MP0005409_darkened_coat_color | 2.52674327 |
| 12 | MP0003787_abnormal_imprinting | 2.50814848 |
| 13 | MP0004742_abnormal_vestibular_system | 2.42004092 |
| 14 | MP0000778_abnormal_nervous_system | 2.41908910 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.33008738 |
| 16 | MP0004859_abnormal_synaptic_plasticity | 2.28128522 |
| 17 | MP0002064_seizures | 2.22371936 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.20385248 |
| 19 | MP0006276_abnormal_autonomic_nervous | 2.13269101 |
| 20 | MP0004142_abnormal_muscle_tone | 2.11108999 |
| 21 | MP0009745_abnormal_behavioral_response | 2.08680283 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 2.06556673 |
| 23 | MP0009046_muscle_twitch | 2.00297378 |
| 24 | MP0009379_abnormal_foot_pigmentation | 2.00041118 |
| 25 | MP0003136_yellow_coat_color | 1.99552332 |
| 26 | MP0001485_abnormal_pinna_reflex | 1.98283091 |
| 27 | MP0008877_abnormal_DNA_methylation | 1.98000558 |
| 28 | MP0002572_abnormal_emotion/affect_behav | 1.97926015 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.89011813 |
| 30 | MP0002063_abnormal_learning/memory/cond | 1.85040923 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.83728158 |
| 32 | MP0002653_abnormal_ependyma_morphology | 1.82115031 |
| 33 | MP0001984_abnormal_olfaction | 1.74694215 |
| 34 | MP0002736_abnormal_nociception_after | 1.71540002 |
| 35 | MP0006072_abnormal_retinal_apoptosis | 1.70385794 |
| 36 | MP0005084_abnormal_gallbladder_morpholo | 1.69920580 |
| 37 | MP0003634_abnormal_glial_cell | 1.69615970 |
| 38 | MP0002837_dystrophic_cardiac_calcinosis | 1.68660157 |
| 39 | MP0003690_abnormal_glial_cell | 1.68588807 |
| 40 | MP0002184_abnormal_innervation | 1.64675118 |
| 41 | MP0004885_abnormal_endolymph | 1.63465109 |
| 42 | MP0008995_early_reproductive_senescence | 1.62024281 |
| 43 | MP0001440_abnormal_grooming_behavior | 1.61397235 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.61152454 |
| 45 | MP0002229_neurodegeneration | 1.59882846 |
| 46 | MP0003329_amyloid_beta_deposits | 1.58689781 |
| 47 | MP0001970_abnormal_pain_threshold | 1.55892119 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.54637202 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.53349413 |
| 50 | MP0003121_genomic_imprinting | 1.52772753 |
| 51 | MP0002735_abnormal_chemical_nociception | 1.52277682 |
| 52 | MP0002733_abnormal_thermal_nociception | 1.50234935 |
| 53 | MP0001188_hyperpigmentation | 1.49183573 |
| 54 | MP0005645_abnormal_hypothalamus_physiol | 1.46174260 |
| 55 | MP0005386_behavior/neurological_phenoty | 1.45251575 |
| 56 | MP0004924_abnormal_behavior | 1.45251575 |
| 57 | MP0000955_abnormal_spinal_cord | 1.42790305 |
| 58 | MP0005171_absent_coat_pigmentation | 1.42244094 |
| 59 | MP0002752_abnormal_somatic_nervous | 1.40190698 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.36846858 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 1.36088939 |
| 62 | MP0001963_abnormal_hearing_physiology | 1.33587127 |
| 63 | MP0000631_abnormal_neuroendocrine_gland | 1.30031767 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 1.28913378 |
| 65 | MP0008569_lethality_at_weaning | 1.28068672 |
| 66 | MP0002638_abnormal_pupillary_reflex | 1.26122783 |
| 67 | MP0005253_abnormal_eye_physiology | 1.24555350 |
| 68 | MP0002234_abnormal_pharynx_morphology | 1.24340592 |
| 69 | MP0008058_abnormal_DNA_repair | 1.23241029 |
| 70 | MP0005195_abnormal_posterior_eye | 1.21501205 |
| 71 | MP0002102_abnormal_ear_morphology | 1.19023631 |
| 72 | MP0005410_abnormal_fertilization | 1.17272384 |
| 73 | MP0000372_irregular_coat_pigmentation | 1.17126582 |
| 74 | MP0000026_abnormal_inner_ear | 1.17062090 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 1.14338698 |
| 76 | MP0003632_abnormal_nervous_system | 1.13137674 |
| 77 | MP0003878_abnormal_ear_physiology | 1.11986486 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 1.11986486 |
| 79 | MP0001502_abnormal_circadian_rhythm | 1.10017530 |
| 80 | MP0002152_abnormal_brain_morphology | 1.07159553 |
| 81 | MP0000749_muscle_degeneration | 1.07123919 |
| 82 | MP0004134_abnormal_chest_morphology | 1.04844991 |
| 83 | MP0004381_abnormal_hair_follicle | 1.04297885 |
| 84 | MP0002938_white_spotting | 1.04192209 |
| 85 | MP0003938_abnormal_ear_development | 1.04147043 |
| 86 | MP0001501_abnormal_sleep_pattern | 1.03144958 |
| 87 | MP0000462_abnormal_digestive_system | 1.02935811 |
| 88 | MP0004147_increased_porphyrin_level | 0.97548002 |
| 89 | MP0005266_abnormal_metabolism | 0.94408789 |
| 90 | MP0001661_extended_life_span | 0.93777558 |
| 91 | MP0008789_abnormal_olfactory_epithelium | 0.93637722 |
| 92 | MP0004133_heterotaxia | 0.92784500 |
| 93 | MP0000566_synostosis | 0.92408015 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.92083157 |
| 95 | MP0003631_nervous_system_phenotype | 0.91319645 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 0.91112636 |
| 97 | MP0003011_delayed_dark_adaptation | 0.90818066 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.90407758 |
| 99 | MP0008872_abnormal_physiological_respon | 0.89028664 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.86946979 |
| 101 | MP0005646_abnormal_pituitary_gland | 0.86297232 |
| 102 | MP0003122_maternal_imprinting | 0.86251575 |
| 103 | MP0002106_abnormal_muscle_physiology | 0.85296238 |
| 104 | MP0003186_abnormal_redox_activity | 0.84246658 |
| 105 | MP0004811_abnormal_neuron_physiology | 0.83207232 |
| 106 | MP0006292_abnormal_olfactory_placode | 0.82017163 |
| 107 | MP0002751_abnormal_autonomic_nervous | 0.81961849 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.81836247 |
| 109 | MP0000750_abnormal_muscle_regeneration | 0.78045132 |
| 110 | MP0005499_abnormal_olfactory_system | 0.77643634 |
| 111 | MP0005394_taste/olfaction_phenotype | 0.77643634 |
| 112 | MP0002090_abnormal_vision | 0.77596571 |
| 113 | MP0002928_abnormal_bile_duct | 0.77086501 |
| 114 | MP0000751_myopathy | 0.75398620 |
| 115 | MP0000013_abnormal_adipose_tissue | 0.74859483 |
| 116 | MP0003718_maternal_effect | 0.74432378 |
| 117 | MP0003633_abnormal_nervous_system | 0.73859871 |
| 118 | MP0003786_premature_aging | 0.73471680 |
| 119 | MP0002876_abnormal_thyroid_physiology | 0.72575264 |
| 120 | MP0003861_abnormal_nervous_system | 0.72167347 |
| 121 | MP0002095_abnormal_skin_pigmentation | 0.71896998 |
| 122 | MP0001299_abnormal_eye_distance/ | 0.71275171 |
| 123 | MP0000015_abnormal_ear_pigmentation | 0.70283291 |
| 124 | MP0002163_abnormal_gland_morphology | 0.67485313 |
| 125 | MP0000049_abnormal_middle_ear | 0.64204334 |
| 126 | MP0004085_abnormal_heartbeat | 0.60305979 |
| 127 | MP0001346_abnormal_lacrimal_gland | 0.57995403 |
| 128 | MP0004043_abnormal_pH_regulation | 0.57736797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 5.01236975 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.84279843 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.84279843 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.40050533 |
| 5 | Neurofibrillary tangles (HP:0002185) | 4.36283741 |
| 6 | Abnormality of glycolysis (HP:0004366) | 3.87708580 |
| 7 | Increased serum pyruvate (HP:0003542) | 3.87708580 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.80917170 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.79865564 |
| 10 | Abnormality of the corticospinal tract (HP:0002492) | 3.72300623 |
| 11 | Progressive macrocephaly (HP:0004481) | 3.72075213 |
| 12 | Renal Fanconi syndrome (HP:0001994) | 3.62154545 |
| 13 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.57358950 |
| 14 | Acute encephalopathy (HP:0006846) | 3.41573703 |
| 15 | Retinal dysplasia (HP:0007973) | 3.35127256 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.33668523 |
| 17 | Increased hepatocellular lipid droplets (HP:0006565) | 3.33391655 |
| 18 | Myokymia (HP:0002411) | 3.33256314 |
| 19 | Leukodystrophy (HP:0002415) | 3.26558128 |
| 20 | Hepatocellular necrosis (HP:0001404) | 3.20135722 |
| 21 | Sensory axonal neuropathy (HP:0003390) | 3.19269677 |
| 22 | Molar tooth sign on MRI (HP:0002419) | 3.13014640 |
| 23 | Abnormality of midbrain morphology (HP:0002418) | 3.13014640 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 3.02025328 |
| 25 | Spastic gait (HP:0002064) | 2.92736207 |
| 26 | Focal motor seizures (HP:0011153) | 2.85772012 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 2.84788357 |
| 28 | Increased CSF lactate (HP:0002490) | 2.83936229 |
| 29 | Lipid accumulation in hepatocytes (HP:0006561) | 2.83662292 |
| 30 | Abnormal number of erythroid precursors (HP:0012131) | 2.81983676 |
| 31 | Pancreatic cysts (HP:0001737) | 2.81190883 |
| 32 | Pancreatic fibrosis (HP:0100732) | 2.80891885 |
| 33 | Peripheral hypomyelination (HP:0007182) | 2.77783491 |
| 34 | Optic disc pallor (HP:0000543) | 2.73869671 |
| 35 | Muscle fiber atrophy (HP:0100295) | 2.72834733 |
| 36 | True hermaphroditism (HP:0010459) | 2.72063288 |
| 37 | Hypoplastic pelvis (HP:0008839) | 2.69762934 |
| 38 | Nephronophthisis (HP:0000090) | 2.66985094 |
| 39 | Abnormality of the labia minora (HP:0012880) | 2.63241828 |
| 40 | Lactic acidosis (HP:0003128) | 2.62659871 |
| 41 | Gait imbalance (HP:0002141) | 2.57148106 |
| 42 | Ankle clonus (HP:0011448) | 2.54736339 |
| 43 | Increased muscle lipid content (HP:0009058) | 2.53325451 |
| 44 | Medial flaring of the eyebrow (HP:0010747) | 2.51972457 |
| 45 | Muscle fiber inclusion bodies (HP:0100299) | 2.51782456 |
| 46 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.50695736 |
| 47 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.49033410 |
| 48 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.47451925 |
| 49 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.47451925 |
| 50 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.47398875 |
| 51 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.47279862 |
| 52 | Increased serum lactate (HP:0002151) | 2.46960324 |
| 53 | Akinesia (HP:0002304) | 2.46893060 |
| 54 | Atonic seizures (HP:0010819) | 2.46238952 |
| 55 | Epileptic encephalopathy (HP:0200134) | 2.44116544 |
| 56 | Limb dystonia (HP:0002451) | 2.43497183 |
| 57 | Lissencephaly (HP:0001339) | 2.37497674 |
| 58 | Nemaline bodies (HP:0003798) | 2.35561355 |
| 59 | Anteriorly placed anus (HP:0001545) | 2.35282925 |
| 60 | Chronic sinusitis (HP:0011109) | 2.31206521 |
| 61 | Vaginal atresia (HP:0000148) | 2.30165407 |
| 62 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.29764269 |
| 63 | Colon cancer (HP:0003003) | 2.29216347 |
| 64 | Exercise-induced muscle cramps (HP:0003710) | 2.26221677 |
| 65 | Rib fusion (HP:0000902) | 2.26132780 |
| 66 | Cerebral hypomyelination (HP:0006808) | 2.25843798 |
| 67 | Genital tract atresia (HP:0001827) | 2.24699303 |
| 68 | Abnormality of renal resorption (HP:0011038) | 2.24360344 |
| 69 | Hepatic necrosis (HP:0002605) | 2.23575854 |
| 70 | Absent septum pellucidum (HP:0001331) | 2.23476925 |
| 71 | Chronic otitis media (HP:0000389) | 2.22982475 |
| 72 | Absent/shortened dynein arms (HP:0200106) | 2.21493796 |
| 73 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.21493796 |
| 74 | Patellar aplasia (HP:0006443) | 2.19063025 |
| 75 | Congenital primary aphakia (HP:0007707) | 2.17637259 |
| 76 | Pheochromocytoma (HP:0002666) | 2.17206062 |
| 77 | Hypoplastic left heart (HP:0004383) | 2.17054466 |
| 78 | Dysmetria (HP:0001310) | 2.16245814 |
| 79 | Respiratory difficulties (HP:0002880) | 2.14327369 |
| 80 | Hyperventilation (HP:0002883) | 2.13898500 |
| 81 | Abnormality of the renal medulla (HP:0100957) | 2.13145865 |
| 82 | Increased intramyocellular lipid droplets (HP:0012240) | 2.12114719 |
| 83 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.11751901 |
| 84 | Pachygyria (HP:0001302) | 2.11275699 |
| 85 | Nephrogenic diabetes insipidus (HP:0009806) | 2.08521984 |
| 86 | Rimmed vacuoles (HP:0003805) | 2.05442454 |
| 87 | Scanning speech (HP:0002168) | 2.04869304 |
| 88 | Neuroendocrine neoplasm (HP:0100634) | 2.04451705 |
| 89 | X-linked dominant inheritance (HP:0001423) | 2.03568639 |
| 90 | Focal seizures (HP:0007359) | 2.02746717 |
| 91 | Abnormality of the septum pellucidum (HP:0007375) | 2.02451800 |
| 92 | Broad-based gait (HP:0002136) | 2.02213844 |
| 93 | Respiratory failure (HP:0002878) | 2.02162613 |
| 94 | Chronic hepatic failure (HP:0100626) | 2.02152949 |
| 95 | Progressive inability to walk (HP:0002505) | 2.02137735 |
| 96 | Exertional dyspnea (HP:0002875) | 2.00993880 |
| 97 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.00482117 |
| 98 | Termporal pattern (HP:0011008) | 2.00170668 |
| 99 | Insidious onset (HP:0003587) | 2.00170668 |
| 100 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.98324984 |
| 101 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.98324984 |
| 102 | Methylmalonic acidemia (HP:0002912) | 1.97469646 |
| 103 | Congenital stationary night blindness (HP:0007642) | 1.97421245 |
| 104 | Sclerocornea (HP:0000647) | 1.96953585 |
| 105 | Adrenal hypoplasia (HP:0000835) | 1.93712293 |
| 106 | Dicarboxylic aciduria (HP:0003215) | 1.92926304 |
| 107 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92926304 |
| 108 | Renal cortical cysts (HP:0000803) | 1.92800113 |
| 109 | Cerebral hemorrhage (HP:0001342) | 1.92699338 |
| 110 | Myelomeningocele (HP:0002475) | 1.92153257 |
| 111 | Alacrima (HP:0000522) | 1.92120304 |
| 112 | Anencephaly (HP:0002323) | 1.91978517 |
| 113 | Methylmalonic aciduria (HP:0012120) | 1.91752310 |
| 114 | Abolished electroretinogram (ERG) (HP:0000550) | 1.91400664 |
| 115 | Hypothermia (HP:0002045) | 1.91131476 |
| 116 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.91113114 |
| 117 | Hyperglycinemia (HP:0002154) | 1.91105849 |
| 118 | Severe muscular hypotonia (HP:0006829) | 1.90486708 |
| 119 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.89358156 |
| 120 | Hypoplasia of the brainstem (HP:0002365) | 1.89358156 |
| 121 | Progressive cerebellar ataxia (HP:0002073) | 1.89293953 |
| 122 | Intention tremor (HP:0002080) | 1.88833266 |
| 123 | Morphological abnormality of the inner ear (HP:0011390) | 1.88057035 |
| 124 | Abnormal ciliary motility (HP:0012262) | 1.87340351 |
| 125 | Dialeptic seizures (HP:0011146) | 1.86625124 |
| 126 | Exercise intolerance (HP:0003546) | 1.86225968 |
| 127 | Abnormality of the renal cortex (HP:0011035) | 1.85254629 |
| 128 | Cerebral edema (HP:0002181) | 1.84855307 |
| 129 | Distal arthrogryposis (HP:0005684) | 1.84248243 |
| 130 | Abnormality of macular pigmentation (HP:0008002) | 1.84247311 |
| 131 | Anomalous pulmonary venous return (HP:0010772) | 1.83790213 |
| 132 | Lethargy (HP:0001254) | 1.82914921 |
| 133 | Calf muscle hypertrophy (HP:0008981) | 1.82429535 |
| 134 | Split foot (HP:0001839) | 1.81968143 |
| 135 | Onion bulb formation (HP:0003383) | 1.81074456 |
| 136 | Increased corneal curvature (HP:0100692) | 1.80834055 |
| 137 | Keratoconus (HP:0000563) | 1.80834055 |
| 138 | Type II lissencephaly (HP:0007260) | 1.80632583 |
| 139 | Cupped ear (HP:0000378) | 1.79822803 |
| 140 | Synostosis involving the elbow (HP:0003938) | 1.79668554 |
| 141 | Humeroradial synostosis (HP:0003041) | 1.79668554 |
| 142 | Partial agenesis of the corpus callosum (HP:0001338) | 1.79432924 |
| 143 | Hemiparesis (HP:0001269) | 1.77858725 |
| 144 | Reticulocytopenia (HP:0001896) | 1.77235370 |
| 145 | Septo-optic dysplasia (HP:0100842) | 1.76718804 |
| 146 | Thickened helices (HP:0000391) | 1.75048464 |
| 147 | Emotional lability (HP:0000712) | 1.74776949 |
| 148 | Myotonia (HP:0002486) | 1.74694477 |
| 149 | Polyphagia (HP:0002591) | 1.74689074 |
| 150 | Growth hormone deficiency (HP:0000824) | 1.72994930 |
| 151 | Abnormality of urine glucose concentration (HP:0011016) | 1.72455855 |
| 152 | Glycosuria (HP:0003076) | 1.72455855 |
| 153 | Optic nerve hypoplasia (HP:0000609) | 1.72103545 |
| 154 | Progressive microcephaly (HP:0000253) | 1.71681460 |
| 155 | Hypoplastic heart (HP:0001961) | 1.71411600 |
| 156 | Large for gestational age (HP:0001520) | 1.70000983 |
| 157 | Poor suck (HP:0002033) | 1.69910222 |
| 158 | Optic nerve coloboma (HP:0000588) | 1.69905144 |
| 159 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67512832 |
| 160 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.66933864 |
| 161 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.64974963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.24744327 |
| 2 | OXSR1 | 3.34905954 |
| 3 | VRK2 | 3.18603536 |
| 4 | TNIK | 3.18165320 |
| 5 | BCKDK | 2.87054384 |
| 6 | CASK | 2.72804201 |
| 7 | MARK1 | 2.71294944 |
| 8 | CDK19 | 2.55612324 |
| 9 | BCR | 2.52780173 |
| 10 | MAP4K2 | 2.44405172 |
| 11 | UHMK1 | 2.35281404 |
| 12 | PNCK | 2.27312662 |
| 13 | EPHB1 | 2.19191209 |
| 14 | ZAK | 2.18494383 |
| 15 | MAPKAPK5 | 2.11713790 |
| 16 | PINK1 | 2.10334773 |
| 17 | NUAK1 | 2.09733305 |
| 18 | MAPK13 | 2.09278996 |
| 19 | STK16 | 2.08303834 |
| 20 | CSNK1G3 | 2.06418686 |
| 21 | DYRK2 | 1.98026507 |
| 22 | PKN1 | 1.95591924 |
| 23 | CSNK1A1L | 1.69784450 |
| 24 | WNK4 | 1.69270860 |
| 25 | FGR | 1.68485078 |
| 26 | NTRK2 | 1.64548598 |
| 27 | PBK | 1.63139620 |
| 28 | CSNK1G2 | 1.57619973 |
| 29 | LIMK1 | 1.53958083 |
| 30 | CSNK1G1 | 1.51656881 |
| 31 | MAP2K7 | 1.44179810 |
| 32 | CAMK2B | 1.43523613 |
| 33 | DYRK3 | 1.40204142 |
| 34 | NME1 | 1.32717178 |
| 35 | FGFR2 | 1.29815102 |
| 36 | MUSK | 1.27335039 |
| 37 | BMPR1B | 1.26851829 |
| 38 | SRPK1 | 1.25631231 |
| 39 | TRIM28 | 1.22440270 |
| 40 | PHKG1 | 1.20874411 |
| 41 | PHKG2 | 1.20874411 |
| 42 | MAP2K4 | 1.19667994 |
| 43 | FRK | 1.18328926 |
| 44 | INSRR | 1.14846699 |
| 45 | MAP3K4 | 1.13789112 |
| 46 | ROCK2 | 1.08348455 |
| 47 | TAF1 | 1.05552714 |
| 48 | GRK7 | 1.05428940 |
| 49 | CAMK2D | 1.04301028 |
| 50 | CAMK2A | 1.02883229 |
| 51 | NTRK3 | 1.01921119 |
| 52 | PRPF4B | 1.01775769 |
| 53 | ARAF | 1.01754306 |
| 54 | CDK5 | 0.99049063 |
| 55 | NEK6 | 0.96407910 |
| 56 | EPHA4 | 0.95702804 |
| 57 | CLK1 | 0.94339005 |
| 58 | CDK14 | 0.94155866 |
| 59 | CDC7 | 0.93232979 |
| 60 | MARK2 | 0.91659056 |
| 61 | MKNK1 | 0.91348908 |
| 62 | WNK3 | 0.91240741 |
| 63 | AURKA | 0.89374332 |
| 64 | MAPK15 | 0.88999708 |
| 65 | WNK1 | 0.88601099 |
| 66 | DYRK1A | 0.88214214 |
| 67 | FES | 0.85789633 |
| 68 | CDK15 | 0.85380007 |
| 69 | GRK5 | 0.85188053 |
| 70 | CDK18 | 0.84158845 |
| 71 | PRKCE | 0.83983873 |
| 72 | SGK494 | 0.83723880 |
| 73 | SGK223 | 0.83723880 |
| 74 | PIM2 | 0.79876263 |
| 75 | CDK11A | 0.79418717 |
| 76 | TESK2 | 0.79124376 |
| 77 | KDR | 0.78220608 |
| 78 | CCNB1 | 0.77600497 |
| 79 | NTRK1 | 0.76485707 |
| 80 | YES1 | 0.76342315 |
| 81 | TYRO3 | 0.76014791 |
| 82 | TAOK3 | 0.75417121 |
| 83 | CAMK2G | 0.74499728 |
| 84 | MST4 | 0.73804524 |
| 85 | GRK1 | 0.72126771 |
| 86 | PAK6 | 0.69806659 |
| 87 | SIK2 | 0.68969914 |
| 88 | MET | 0.67590142 |
| 89 | MINK1 | 0.66332086 |
| 90 | ADRBK2 | 0.66306545 |
| 91 | EPHB2 | 0.65129587 |
| 92 | DYRK1B | 0.63441121 |
| 93 | ICK | 0.63365863 |
| 94 | VRK1 | 0.62183620 |
| 95 | MAP3K12 | 0.61621638 |
| 96 | PAK3 | 0.61355532 |
| 97 | PASK | 0.57244883 |
| 98 | RPS6KA5 | 0.56872089 |
| 99 | PRKCQ | 0.55811672 |
| 100 | PLK4 | 0.55801928 |
| 101 | ADRBK1 | 0.55637874 |
| 102 | PRKCG | 0.55354774 |
| 103 | BMPR2 | 0.53518712 |
| 104 | IRAK2 | 0.53387076 |
| 105 | PRKG1 | 0.51607314 |
| 106 | PIK3CG | 0.51441154 |
| 107 | BRSK1 | 0.50623858 |
| 108 | MAP3K11 | 0.50044077 |
| 109 | FYN | 0.48604705 |
| 110 | DAPK3 | 0.47809951 |
| 111 | MAPK4 | 0.47106817 |
| 112 | PRKACA | 0.47031342 |
| 113 | ATR | 0.46783054 |
| 114 | TIE1 | 0.46422707 |
| 115 | KIT | 0.46140552 |
| 116 | MAPK12 | 0.46092593 |
| 117 | SYK | 0.44473304 |
| 118 | CDK3 | 0.43752704 |
| 119 | PLK1 | 0.41771339 |
| 120 | CSNK2A1 | 0.41216434 |
| 121 | CSNK2A2 | 0.39313392 |
| 122 | OBSCN | 0.38985052 |
| 123 | PRKACB | 0.38973192 |
| 124 | BUB1 | 0.38251099 |
| 125 | NEK1 | 0.37942751 |
| 126 | MAP3K6 | 0.37723898 |
| 127 | HIPK2 | 0.36920096 |
| 128 | PLK3 | 0.36440855 |
| 129 | DAPK2 | 0.35678973 |
| 130 | PRKCZ | 0.35586816 |
| 131 | MARK3 | 0.35577531 |
| 132 | CSNK1A1 | 0.34196191 |
| 133 | ERBB3 | 0.33507782 |
| 134 | CSNK1E | 0.33362341 |
| 135 | TNK2 | 0.32993663 |
| 136 | PLK2 | 0.32193278 |
| 137 | CAMK1G | 0.30233990 |
| 138 | MYLK | 0.30143676 |
| 139 | CDK8 | 0.29228523 |
| 140 | CSNK1D | 0.28764624 |
| 141 | TLK1 | 0.27746070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.45626203 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.08950844 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.63885073 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.56883901 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.41654467 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.07605479 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.89732408 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.85871522 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.54272857 |
| 10 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.27802352 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.19262077 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 2.09745680 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 1.96640859 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.94328062 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.89573803 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.80374517 |
| 17 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.79050707 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.79001378 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.78310451 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.74674965 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.60074991 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.55540287 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.49926675 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.49409821 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.48371283 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.46369832 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.46003053 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41766028 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.40063924 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.35254342 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33478296 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.32422515 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31057524 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.30931286 |
| 35 | Circadian entrainment_Homo sapiens_hsa04713 | 1.24874290 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 1.22103406 |
| 37 | RNA polymerase_Homo sapiens_hsa03020 | 1.21977707 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.21925410 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19275205 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19060281 |
| 41 | Mismatch repair_Homo sapiens_hsa03430 | 1.16344958 |
| 42 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.16138147 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.15978604 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15572752 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.15041652 |
| 46 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.14100082 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.13504925 |
| 48 | Long-term depression_Homo sapiens_hsa04730 | 1.11870708 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10915017 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09516993 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.06051002 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02312643 |
| 53 | DNA replication_Homo sapiens_hsa03030 | 1.01898413 |
| 54 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.01532673 |
| 55 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00314862 |
| 56 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.99032365 |
| 57 | Olfactory transduction_Homo sapiens_hsa04740 | 0.93482119 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93463878 |
| 59 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.92466163 |
| 60 | RNA degradation_Homo sapiens_hsa03018 | 0.91357410 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89209133 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 0.86385869 |
| 63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.83027034 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81524551 |
| 65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80314933 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78490227 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78242288 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77170313 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.75965630 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.74044062 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73702591 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.73433836 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70104229 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69650856 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68082886 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67736572 |
| 77 | Alcoholism_Homo sapiens_hsa05034 | 0.67458004 |
| 78 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66210125 |
| 79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65711363 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65253904 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65106881 |
| 82 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64299938 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63659446 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.62548172 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62157706 |
| 86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.57112321 |
| 87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56597567 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56488342 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55616027 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55016997 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54776074 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54667099 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54121386 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53086272 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.52699102 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.51996997 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50290278 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49897890 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49389034 |
| 100 | Allograft rejection_Homo sapiens_hsa05330 | 0.48516889 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48365484 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.48306924 |
| 103 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47357170 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.46660206 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44227118 |
| 106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42792533 |
| 107 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41234082 |
| 108 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40793924 |
| 109 | RNA transport_Homo sapiens_hsa03013 | 0.40028892 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40000238 |
| 111 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39701889 |
| 112 | Carbon metabolism_Homo sapiens_hsa01200 | 0.39111368 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37253750 |
| 114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36263354 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.35421174 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35393048 |
| 117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35179913 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34165190 |
| 119 | Melanogenesis_Homo sapiens_hsa04916 | 0.33799984 |
| 120 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33601601 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33398403 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33195300 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.32524506 |
| 124 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.32443117 |
| 125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32346926 |
| 126 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31513993 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.31054417 |
| 128 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.30754962 |
| 129 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29340258 |
| 130 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25867325 |
| 131 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25863237 |
| 132 | Tight junction_Homo sapiens_hsa04530 | 0.25226861 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25181457 |
| 134 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22361960 |
| 135 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.22318493 |
| 136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22232083 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.21843390 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21830632 |
| 139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21322423 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20647001 |
| 141 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.18926672 |
| 142 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.18576953 |
| 143 | Purine metabolism_Homo sapiens_hsa00230 | 0.17585593 |
| 144 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.16824927 |
| 145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16344563 |
| 146 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.16182129 |

